The Vanguard Group Discloses Position in Mural Oncology

The Vanguard Group, Inc. has made an opening position disclosure under the Irish Takeover Panel Act, 1997. This concerns their interests in Mural Oncology plc. As of October 1, 2025, Vanguard holds a 1.67% interest in Mural Oncology's ordinary shares, totaling 288,363 shares. This comes under Form 8.3 of the Irish Takeover Panel rules, which requires disclosure by those with 1% or more interests in relevant securities during a takeover situation.

Vanguard's submission indicates no cash-settled or stock-settled derivatives. In their dealings, Vanguard sold 166,349 ordinary shares at a price of 2.07 USD per share. There were no derivative or other complex financial transactions reported. Additionally, Vanguard has stated there are no indemnity arrangements or agreements relating to securities voting rights.